Special Issue "Antibiotics Resistance of Borrelia"
Deadline for manuscript submissions: closed (31 October 2019).
Interests: Lyme disease; spirochetes; infection; biofilm; persisters; antibiotic resistance; connection of cancer to bacterial infections
Special Issues and Collections in MDPI journals
Over the years, the severity of infectious diseases and the inability to effectively treat them using antibiotics has become a rapidly growing epidemic. Lyme disease, which is caused by the spirochete Borrelia, is one of the fastest growing tick-borne multisystemic diseases, with 300,000 reported cases/year just in the United States. While administering antibiotics can be effective for some patients, relapse often occurs when the treatment is discontinued. The reason for relapse remains unknown, but there are recent studies suggesting the presence of “pesisters cells” and biofilm forms with surprisingly high resistance to the antimicrobials currently used to treat Lyme disease. Therefore, there is a pressing need to better understand how these defensive forms can evade our therapeutic treatments with the ultimate goal of finding effective anti-microbials to treat all forms of Borrelia. In this Special Issue on the “Antibiotics Resistance of Borrelia” we will highlight the latest research exploring new strategies to combat Lyme disease.
Prof. Dr. Eva Sapi
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Lyme disease
- drug discovery